Pfizer Announced: Covid-19 Vaccine Won't Catch Up With Presidential Elections

Pfizer Announced: Covid-19 Vaccine Won't Catch Up With Presidential Elections US drug production giant Pfizer announced that the Covid-19 (Coronavirus) vaccine won’t catch up with the presidential elections. US drug maker Pfizer stated that the third week of November should be expected in the best possibility for the official approval application of the new type of Coronavirus (Covid-19) vaccine. An 'open letter' was published on the website by Albert Bourla, the company's senior manager, in order to 'clear the confusion about the vaccine'. The letter published by Bourla contained the following statements: “Let me be clear that Pfizer will apply for Emergency Authorization Use in the US in the third week of November (for the Covid-19 vaccine) after reaching a safe stage, assuming that the data will continue positively.” In the letter, which emphasized that the announced timeline is the estimated good probability date, the letter said that the data will be examined by a public panel formed by independent scientists as well as US Food and Drug Administration (FDA) officials. US President Donald Trump has insisted in his past statements that the Covid-19 (Coronavirus) vaccine will catch up before the presidential elections. Upon this, Pfizer senior manager Albert Bourla wrote in an open letter to his employees on October 5, saying that they were 'on the side of science' about the coronavirus (Covid-19) vaccine and that they would not 'bow to political pressure'. US presidential elections are expected to be held on 3 November.